Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature

The development of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of patients with advanced stage cancers. However, immune-related adverse events are frequently observed. Cardiac toxicity from ICI therapy can range from asymptomatic troponin-I elevations to conduction abnormali...

Full description

Bibliographic Details
Main Authors: Nikhil Agrawal, Arjun Khunger, Pankit Vachhani, Teresa A. Colvin, Alexander Hattoum, Edward Spangenthal, Anne B. Curtis, Grace K. Dy, Marc S. Ernstoff, Igor Puzanov
Format: Article
Language:English
Published: Karger Publishers 2019-03-01
Series:Case Reports in Oncology
Subjects:
Cardiotoxicity
Immune checkpoint inhibitors
Myocarditis
Autoimmune
Cardio-oncology
Online Access:https://www.karger.com/Article/FullText/498985

Internet

https://www.karger.com/Article/FullText/498985

Similar Items